Health Care

UnitedHealth Group Inc Chief Executive Officer Steven Hemsley said on Tuesday that the company would largely exit the Obamacare exchange market in 2017, following through on a warning he had given late last year that costs appeared to be unsustainable.

Blood-testing firm Theranos Inc confirmed on Monday it is under investigation by federal prosecutors and the U.S. Securities and Exchange Commission.

Health insurer UnitedHealth Group raised its expectations for 2016 profit, in part because of a more favorable tax rate that also helped it beat Wall Street expectations for the first quarter.

Johnson & Johnson, the maker of Band-Aids and Tylenol, reported higher-than-expected quarterly earnings on Tuesday and nudged up its 2016 sales and earnings forecasts.

Image source: Pixabay , public domain For this Fool, the rise and fall of Valeant Pharmaceuticals International Inc (NYSE: VRX) is the most fascinating business story of 2015 -- and there are still a few chapters yet to be written.

Image source: Pixabay.

Federal health regulators have proposed banning Theranos Inc. founder Elizabeth Holmes from the blood-testing business for at least two years after concluding that the company failed to fix what regulators have called major problems at its laboratory in California.

SOURCE: FLICKR USER PICTURES OF MONEY.

Source: Flickr.

The health care sector remains one of the worst performing areas of the market, despite the recovery off the Feb. 11 lows.

A Medicare proposal to test new ways of paying for chemotherapy and other drugs given in a doctor's office has sparked a furious battle, and cancer doctors are demanding that the Obama administration scrap the experiment.

What a week on Wall Street! The FOX Business Network All-Stars: Charlie Gasparino, Melissa Francis and Charles Payne have a spirited discussion on the corporate business environment: blocked mergers, complex tax codes, gov’t intervention etc.

Diabetes is not just a health issue. According to the ADA, healthcare costs for people with diabetes are 2.3 times higher than for individuals who do not have diabetes.

KannaLife Sciences CEO Dean Petkanas expects the federal government to pave the way for medical marijuana within two years, he told Varney & Co.